NCT07153406: Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients
- State
- Not started
- Phase
- Phase 3
- People
- 220 planned
- Started
- 15 Sep 2025
- Primary completion
- 15 Sep 2026
- Arms
- Esketamine
- Results
- None posted
- 4 Sep 2025: Trial registered